noac studies in vte
DESCRIPTION
NOAC Studies in VTE. AF Studies Superior Outcomes. Meta-analysis VTE Studies Safety Outcomes Favor NOACs vs VKA. Hokusai. What’s New in the 2014 ESC PE Guidelines?. Prognostic Assessment of Patients With Acute PE. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/1.jpg)
![Page 2: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/2.jpg)
![Page 3: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/3.jpg)
NOAC Studies in VTE
![Page 4: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/4.jpg)
![Page 5: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/5.jpg)
AF Studies Superior Outcomes
![Page 6: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/6.jpg)
Meta-analysis VTE StudiesSafety Outcomes Favor NOACs vs VKA
![Page 7: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/7.jpg)
Hokusai
![Page 8: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/8.jpg)
![Page 9: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/9.jpg)
What’s New in the 2014 ESC PE Guidelines?
![Page 10: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/10.jpg)
Prognostic Assessment of Patients With Acute PE
![Page 11: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/11.jpg)
Acute PE: Based on Early (intermediate) Mortality Risk
Risk Parameters and Scores
![Page 12: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/12.jpg)
ESC 2014PE Anticoagulation Recommendations
![Page 13: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/13.jpg)
Extended Treatment of VTE With NOACs
![Page 14: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/14.jpg)
ESC 2014 Guideline Recommendations for Extended
Treatment Using NOACs
![Page 15: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/15.jpg)
Chronic Thromboembolic Pulmonary Hypertension
![Page 16: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/16.jpg)
Recommendations for the Management of PE in Pregnancy and PE in Patients With Cancer
![Page 17: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/17.jpg)
![Page 18: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/18.jpg)
![Page 19: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/19.jpg)
![Page 20: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/20.jpg)
![Page 21: NOAC Studies in VTE](https://reader035.vdocuments.site/reader035/viewer/2022062300/56812c80550346895d91320d/html5/thumbnails/21.jpg)